Search results for "Complications."

showing 10 items of 1514 documents

Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment.

2009

Head & Neck Cancer (HNC) represents the sixth most common malignancy worldwide and it is historically linked to well-known behavioural risk factors, i.e., tobacco smoking and/or the alcohol consumption. Recently, substantial evidence has been mounting that Human Papillomavirus (HPV) infection is playing an increasing important role in oral cancer. Because of the attention and clamor surrounding oral HPV infection and related cancers, as well as the use of HPV prophylactic vaccines, in this invited perspective the authors raise some questions and review some controversial issues on HPV infection and its role in HNC, with a particular focus on oral squamous cell carcinoma. The problematic def…

Oncologymedicine.medical_specialtyPathologyMalignancyPapillomavirus VaccinesInternal medicineHumansMedicineHuman papilloma virus infectionHPV infection;oral cancer;Papillomavirus VaccinesMouth neoplasmbusiness.industryTransmission (medicine)Papillomavirus InfectionsHPV infectionvirus diseasesCancerGenetic Therapyoral cancerPrognosismedicine.diseaseCombined Modality Therapyfemale genital diseases and pregnancy complicationsstomatognathic diseasesOncologyOtorhinolaryngologyOtorhinolaryngologyHead and Neck NeoplasmsHPV infectionCommentaryMouth Neoplasmsbusiness
researchProduct

Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.

2014

Abstract Background/objectives Cachexia affects ∼80% of pancreatic cancer patients. An international consensus defines cachexia as an ongoing loss of skeletal muscle mass (sarcopenia) with or without loss of fat, which impairs body functioning and cannot be reversed by conventional nutritional measures. Weight loss percentage and elevated inflammation markers have been employed to define this condition earlier. This review aimed to assess the prevalence and consequences of cachexia and sarcopenia on survival in patients with pancreatic ductal adenocarcinoma. Methods The systematic review was performed by searching the articles with preset terms published in PubMed and Cochrane Database unti…

Oncologymedicine.medical_specialtySarcopeniaCachexiaEndocrinology Diabetes and MetabolismOverweightCachexiaWeight lossInternal medicinePancreatic cancerWeight LossmedicinePrevalenceHumansSarcopenic obesityHepatologybusiness.industryConfoundingGastroenterologymedicine.diseasePrognosismusculoskeletal systemPancreatic NeoplasmsSurvival RateCachexia/diagnosis/epidemiology/*etiology; Carcinoma Pancreatic Ductal/*complications/mortality; Humans; Pancreatic Neoplasms/*complications/mortality; Prevalence; Prognosis; Sarcopenia/diagnosis/epidemiology/*etiology; Survival Rate; Weight LossSarcopeniaAdenocarcinomamedicine.symptombusinessCarcinoma Pancreatic Ductal
researchProduct

Vulvar cancer: a review for dermatologists.

2015

Vulvar malignancies are important tumors of the female reproductive system. They represent a serious health issue with an incidence between 2 and 7 per 100,000 and year. We provide a review about most important cancer entities, i.e., melanoma, squamous cell carcinoma, basal cell carcinoma, neuroendocrine cancer, and skin adnexal malignancies. Squamous cell carcinoma is the most common vulvar malignancy that can develop from vulvar intraepithelial neoplasia or de novo. Basal cell carcinoma represents only 2 % of all vulvar cancers. Melanoma of the vulva exists in two major types—superficial spreading and acral lentiginous. A special feature is the occurrence of multiple vulvar melanomas. Of …

Oncologymedicine.medical_specialtySkin NeoplasmsMalignancyVulvaVulvaDiagnosis DifferentialVulva · Squamous cell carcinoma · Basal cell carcinoma · Melanoma · Paget’s disease · Adnexal carcinomasInternal medicineCarcinomamedicineSettore MED/35 - Malattie Cutanee E VenereeHumansBasal cell carcinomaMelanomaNeoplasm StagingSkinintegumentary systemVulvar Neoplasmsurogenital systembusiness.industryMelanomaCancerGeneral MedicineVulvar cancermedicine.diseaseVulvar intraepithelial neoplasiaPrognosisDermatologyfemale genital diseases and pregnancy complicationsNeuroendocrine Tumorsmedicine.anatomical_structurePaget Disease ExtramammaryCarcinoma Basal CellCarcinoma Squamous CellFemaleNeoplasms Adnexal and Skin AppendagebusinessCarcinoma in SituWiener medizinische Wochenschrift (1946)
researchProduct

Hereditary ovarian cancer.

2008

Apoptosis is a form of cell death that permits the removal of damaged, senescent or unwanted cells in multicellular organisms, without damage to the cellular microenvironment. Defective apoptosis represents a major causative factor in the development and progression of cancer. The majority of chemotherapeutic agents, as well as radiation, utilize the apoptotic pathway to induce cancer cell death. Resistance to standard chemotherapeutic strategies also seems to be due to alterations in the apoptotic pathway of cancer cells. Recent knowledge on apoptosis has provided the basis for novel targeted therapies that exploit apoptosis to treat cancer. These new target include those acting in the ext…

Oncologymedicine.medical_specialtyendocrine system diseasesColorectal cancerMLH1Germline mutationNeoplastic Syndromes HereditaryInternal medicineGenetic predispositionMedicineHumansGenetic Predisposition to DiseaseGenetic testingOvarian Neoplasmsmedicine.diagnostic_testbusiness.industryBRCA mutationHematologymedicine.diseasePrognosisfemale genital diseases and pregnancy complicationsovarian cancerOncologyMSH2FemalebusinessOvarian cancer
researchProduct

Peritoneal carcinosis of ovarian origin

2010

Epithelial ovarian cancer (EOC) is the second most common genital malignancy in women and is the most lethal gynecological malignancy, with an estimated five-year survival rate of 39%. Despite efforts to develop an effective ovarian cancer screening method, 60% of patients still present with advanced disease. Comprehensive management using surgical cytoreduction to decrease the tumor load to a minimum, and intraperitoneal chemotherapy to eliminate microscopic disease on peritoneal surface, has the potential to greatly improve quality of life and to have an impact on survival in ovarian cancer patients. Despite achieving clinical remission after completion of initial treatment, most patients…

Oncologymedicine.medical_specialtyendocrine system diseasesbusiness.industryPeritoneal carcinosisGastroenterologyDrug resistancemedicine.diseaseMalignancySettore MED/40 - Ginecologia E Ostetriciafemale genital diseases and pregnancy complicationsSurgeryCytoreductionOvarian cancer Intraperitoneal hyperthermic chemotherapyOncologyQuality of lifePeritoneal carcinosiInternal medicinemedicineSex organTopic HighlightOvarian cancerbusinessSurvival rateTumor LoadWorld Journal of Gastrointestinal Oncology
researchProduct

The road map toward an hepatitis C virus-free transplant population

2018

Antiviral therapy to eradicate hepatitis C virus (HCV) infection improves outcomes in patients undergoing liver transplantation (LT) for advanced chronic HCV with or without hepatocellular carcinoma. Traditionally, antiviral therapy focused on the use of interferon (IFN)-based regimens, with antiviral treatment initiated in the posttransplant period once recurrent HCV disease with fibrosis in the allograft was identified. The use of IFN-based therapy was limited in pretransplant patients with advanced liver disease. Earlier intervention, either before transplantation or early after LT, is now feasible with the advent of second-generation direct-acting antiviral agents (DAAs) with superior t…

Oncologymedicine.medical_specialtymedicine.medical_treatmentHepatitis C virusinfectious diseasePopulationHepacivirus030230 surgeryLiver transplantationmedicine.disease_causeclinical research/practiceinfection and infectious agents—viral: hepatitis CAntiviral Agents03 medical and health sciencesLiver diseasePostoperative Complications0302 clinical medicineeditorial/personal viewpointInternal medicinemedicineHumansImmunology and Allergyliver disease: infectiousPharmacology (medical)educationclinical research/practice; editorial/personal viewpoint; infection and infectious agents—viral: hepatitis C; infectious disease; liver disease: infectious; liver transplantation/hepatology; Immunology and Allergy; Transplantation; Pharmacology (medical)education.field_of_studyTransplantationbusiness.industrymedicine.diseaseHepatitis CLiver TransplantationTransplantationClinical trialhepatitis C infectious disease liver disease: infectious liver transplantation/hepatology [clinical research/practice editorial/personal viewpoint infection and infectious agents-viral]TolerabilityHepatocellular carcinoma030211 gastroenterology & hepatologybusinessliver transplantation/hepatology
researchProduct

Impact of Postoperative Complications on Survival and Recurrence After Resection of Colorectal Liver Metastases

2019

OBJECTIVE To study the effect of postoperative complications (POC) on overall survival (OS) and disease-free survival (DFS) after surgical resection of colorectal liver metastases (CRLM). SUMMARY BACKGROUND DATA Morbidity rates after liver resection can reach 45%. The negative impact of POC on oncologic outcomes has been reported in various types of cancer, especially colorectal. However, data on the consequences of POC after CRLM resection on long-term survival are scarce. METHODS Eligible studies examining the association between POC after CRLM resection and OS/DFS were sought using the PubMed and Web of Science databases. A random-effects model was used to calculate pooled effect estimat…

Oncologymedicine.medical_specialtymedicine.medical_treatmentSubgroup analysisResection03 medical and health sciencesPostoperative Complications0302 clinical medicineInternal medicinemedicineHepatectomyHumansSurvival rateSurvival analysisbusiness.industryLiver NeoplasmsHazard ratioCancermedicine.diseaseSurvival Rate030220 oncology & carcinogenesisMeta-analysis030211 gastroenterology & hepatologySurgeryNeoplasm Recurrence LocalHepatectomyColorectal NeoplasmsbusinessAnnals of Surgery
researchProduct

Polycystic ovary syndrome

2016

Polycystic ovary syndrome (PCOS) affects 5-20% of women of reproductive age worldwide. The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology (PCOM) - with excessive androgen production by the ovaries being a key feature of PCOS. Metabolic dysfunction characterized by insulin resistance and compensatory hyperinsulinaemia is evident in the vast majority of affected individuals. PCOS increases the risk for type 2 diabetes mellitus, gestational diabetes and other pregnancy-related complications, venous thromboembolism, cerebrovascular and cardiovascular events and endometrial cancer. PCOS is a diagnosis of exclusion, based primarily on the p…

OvulationHirsutismmedicine.medical_specialtyendocrine system diseases030209 endocrinology & metabolismOvaryPathogenesis03 medical and health sciences0302 clinical medicineInsulin resistanceSDG 3 - Good Health and Well-beingRisk FactorsInternal medicineAcne VulgarismedicineHumansCongenital adrenal hyperplasiaObesityAbdominal obesityhirsutism030219 obstetrics & reproductive medicinebusiness.industryOvaryHyperandrogenismAlopeciaGeneral Medicinemedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsEndocrinologymedicine.anatomical_structureAndrogensQuality of LifeFemalemedicine.symptomHyperandrogenismbusinessPolycystic Ovary SyndromeNature Reviews Disease Primers
researchProduct

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

2009

Abstract OBJECTIVE: To review all available data and recommend a definition for polycystic ovary syndrome (PCOS) based on published peer-reviewed data, whether already in use or not, to guide clinical diagnosis and future research. DESIGN: Literature review and expert consensus. SETTING: Professional society. PATIENTS: None. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): A systematic review of the published peer-reviewed medical literature, by querying MEDLINE databases, to identify studies evaluating the epidemiology or phenotypic aspects of PCOS. RESULT(S): The Task Force drafted the initial report, following a consensus process via electronic communication, which was then reviewed and c…

Ovulationmedicine.medical_specialtySettore MED/09 - Medicina Internaendocrine system diseasesMEDLINEPCOS Fertility Anovulation Menstrual irregularities Obesity Hyperandrogenism Ovarian function Ovarian ultrasoundsSettore MED/13 - EndocrinologiaDiagnosis DifferentialPredictive Value of TestsIntervention (counseling)Terminology as TopicEpidemiologymedicineHealth Status IndicatorsHumanshirsutismMenstruation DisturbancesOvarian Function TestsGynecologyEvidence-Based Medicinebusiness.industryHyperandrogenismOvaryObstetrics and GynecologyEvidence-based medicinemedicine.diseasePolycystic ovarySettore MED/40 - Ginecologia E Ostetriciafemale genital diseases and pregnancy complicationsPhenotypeReproductive MedicineFemalebusinessHyperandrogenismBiomarkersMedical literatureClinical psychologyPolycystic Ovary SyndromeFertility and sterility
researchProduct

23-hour observation endocrine neck surgery: lessons learned from a case series of over 1700 patients

2017

Although the surgical procedures concerning the thyroid and the parathyroid glands are considered safe, the possible occurrence of complications (mainly hematoma and hypocalcemia) limit the short stay surgery. At our institution a 23-hour-surgery with overnight hospital stay for endocrine neck surgical procedures was introduced since 2004. The present case series analyses the institutional results. Over 1913 endocrine neck surgery procedures, 1730 patients (90,2%) were managed according to this model. Among these patients, 92 suffered from hypocalcemia, 12 from airways obstruction due to the hematoma, 5 from bilateral nerve palsy. 15 more patients had unpredictable general disease compromis…

Parathyroidectomymedicine.medical_specialtyTime Factorsmedicine.medical_treatment030230 surgeryENDOCRINE SURGERY03 medical and health sciencesPostoperative Complications0302 clinical medicineHematomaTHYROIDHumansMedicineEndocrine systemMonitoring PhysiologicParathyroidectomyPostoperative Carebusiness.industryThyroidThyroidectomyLength of StaySurgical proceduresmedicine.diseaseShort stay surgerySurgeryEndocrine surgeryTreatment Outcomemedicine.anatomical_structure030220 oncology & carcinogenesisThyroidectomyOriginal Articlebusiness
researchProduct